Skip to main navigation
about geron
leadership
our culture & values
life at geron
careers
responsibility
focus areas
LR-Myelodysplastic Syndromes (LR-MDS)
Myelofibrosis (MF)
glossary of terms
our medicine
our science
telomerase inhibition
publications & posters
clinical trials
investigator-sponsored research
patients & families
patient stories
advocacy & support
expanded access
news
thought leadership articles
press releases
event landing pages
investors
News & Events
News Releases
Events & Presentations
Publications
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Analyst Coverage
Financials
SEC filings
Quarterly Results
Annual Reports
Governance
Documents & Charters
Board of Directors
Management Team
Committee Composition
Shareholder Resources
Investor FAQs
Email Alerts
Contact Us
careers
contact
about geron
leadership
our culture & values
life at geron
careers
responsibility
focus areas
LR-Myelodysplastic Syndromes (LR-MDS)
Myelofibrosis (MF)
glossary of terms
our medicine
our science
telomerase inhibition
publications & posters
clinical trials
investigator-sponsored research
patients & families
patient stories
advocacy & support
expanded access
news
thought leadership articles
press releases
event landing pages
investors
News & Events
News Releases
Events & Presentations
Publications
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Analyst Coverage
Financials
SEC filings
Quarterly Results
Annual Reports
Governance
Documents & Charters
Board of Directors
Management Team
Committee Composition
Shareholder Resources
Investor FAQs
Email Alerts
Contact Us
careers
contact
Contact Us
Investor FAQs
Email Alerts
Contact Us
Name
Email
Subject
Comments
Leave this field blank
Investor Contact
investor@geron.com
Media Relations
media@geron.com
Subscribe to Email Alerts
Email
*
Submit
